Annexure H: Interest in subsidiary companies and joint ventures

  Shareholding  
  2016
R’000		   2015
R’000		  
Subsidiaries        
Adcock Ingram Limited 100   100  
Adcock Ingram Healthcare Proprietary Limited 100   100  
Adcock Ingram Intellectual Property Proprietary Limited 100   100  
Adcock Ignram Critical Care Proprietary Limited 100   100  
Adcock Ingram International Proprietary Limited 100   100  
Tender Loving Care – Hygienic, Cosmetic and Baby Products Proprietary Limited 100   100  
Joint ventures        
Thembalami Pharmaceuticals Proprietary Limited 50   50  
Adcock Ingram Limited (India) 49,9   49,9  
Indirect holdings        
Adcock Ingram Pharmaceuticals Proprietary Limited 100   100  
Premier Pharmaceutical Company Proprietary Limited 100   100  
Metamorphosa Proprietary Limited 50   50  
Menarini SA Proprietary Limited ** 49   49  
Novartis Ophthalmics Proprietary Limited ** 49   49  
Addclin Research Proprietary Limited 100   100  
Adcock Ingram Intellectual Property No 1 Proprietary Limited 100   100  
Dilwed Investments Proprietary Limited 100   100  
Adcock Ingram Namibia Proprietary Limited 100   100  
National Renal Care Proprietary Limited 50   50  
Pharmalabs (Jersey) Limited 100   100  
Datlabs (Private) Limited 100   100  
Adcock Ingram Healthcare Private Limited (India) 100   100  
Adcock Ingram East Africa Limited 100   100  
Ayrton Drug Manufacturing Limited (Ghana) 78,57   78,57  
Ayrton Drug Manufacturing Limited (Sierra Leone) 78,57   78,57  
Trusts and structured entities        
Adcock Ingram Holdings Limited Employee Share Trust (2008)        
Mpho ea Bophelo Trust        
AdBEE (RF) Limited*        
Ad-Izinyosi Proprietary Limited*        
19 Owner-driver companies (2015: 19 companies)        
* Not consolidated – refer accounting policies
** Regarded as subsidiaries